Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0104 Transporter Info | ||||
Gene Name | SLC16A13 | ||||
Transporter Name | Monocarboxylate transporter 13 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC16A13 Modification Sites with Functional and Structural Information | |||||
Sequence |
MARRTEPPDG GWGWVVVLSA FFQSALVFGV LRSFGVFFVE FVAAFEEQAA RVSWIASIGI
AVQQFGSPVG SALSTKFGPR PVVMTGGILA ALGMLLASFA TSLTHLYLSI GLLSGSGWAL TFAPTLACLS CYFSRRRSLA TGLALTGVGL SSFTFAPFFQ WLLSHYAWRG SLLLVSALSL HLVACGALLR PPSLAEDPAV GGPRAQLTSL LHHGPFLRYT VALTLINTGY FIPYLHLVAH LQDLDWDPLP AAFLLSVVAI SDLVGRVVSG WLGDAVPGPV TRLLMLWTTL TGVSLALFPV AQAPTALVAL AVAYGFTSGA LAPLAFSVLP ELIGTRRIYC GLGLLQMIES IGGLLGPPLS GYLRDVTGNY TASFVVAGAF LLSGSGILLT LPHFFCFSTT TSGPQDLVTE ALDTKVPLPK EGLEED |
||||
PTM type |
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
Phosphorylation |
|||||
---|---|---|---|---|---|
Serine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC16A13 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
350 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC16A13 Serine 350 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC16A13 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
360 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC16A13 Serine 360 has the potential to affect its expression or activity. | ||||
Tyrosine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC16A13 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
339 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC16A13 Tyrosine 339 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC16A13 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
362 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC16A13 Tyrosine 362 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Lysine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC16A13 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
415 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC16A13 Lysine 415 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC16A13 | [3] , [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
420 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC16A13 Lysine 420 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.